GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Succeeder Technology Inc (SHSE:688338) » Definitions » PB Ratio

Beijing Succeeder Technology (SHSE:688338) PB Ratio : 1.52 (As of Apr. 10, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Succeeder Technology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-10), Beijing Succeeder Technology's share price is ¥23.38. Beijing Succeeder Technology's Book Value per Share for the quarter that ended in Sep. 2024 was ¥15.41. Hence, Beijing Succeeder Technology's PB Ratio of today is 1.52.

The historical rank and industry rank for Beijing Succeeder Technology's PB Ratio or its related term are showing as below:

SHSE:688338' s PB Ratio Range Over the Past 10 Years
Min: 1.3   Med: 2.26   Max: 23.61
Current: 1.52

During the past 8 years, Beijing Succeeder Technology's highest PB Ratio was 23.61. The lowest was 1.30. And the median was 2.26.

SHSE:688338's PB Ratio is ranked better than
62.41% of 790 companies
in the Medical Devices & Instruments industry
Industry Median: 2.025 vs SHSE:688338: 1.52

During the past 12 months, Beijing Succeeder Technology's average Book Value Per Share Growth Rate was 4.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 41.10% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Beijing Succeeder Technology was 87.30% per year. The lowest was 5.70% per year. And the median was 47.10% per year.

Back to Basics: PB Ratio


Beijing Succeeder Technology PB Ratio Historical Data

The historical data trend for Beijing Succeeder Technology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Succeeder Technology PB Ratio Chart

Beijing Succeeder Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - 3.37 2.56 1.79 2.23

Beijing Succeeder Technology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.27 2.23 1.63 1.41 1.65

Competitive Comparison of Beijing Succeeder Technology's PB Ratio

For the Medical Devices subindustry, Beijing Succeeder Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Succeeder Technology's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Succeeder Technology's PB Ratio falls into.


;
;

Beijing Succeeder Technology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Beijing Succeeder Technology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=23.38/15.408
=1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Beijing Succeeder Technology  (SHSE:688338) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Beijing Succeeder Technology PB Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Succeeder Technology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Succeeder Technology Business Description

Traded in Other Exchanges
N/A
Address
Innovation Road, No. 1, Xingchang Road, Block 1A, No. 27, Science and Technology Park, 3rd Floor, Building 1, Changping District, East District, East District, Beijing, CHN, 102200
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
Executives
Le Jia Min Core technical personnel
Yu Song Yan Core technical personnel
Li Gang Core technical personnel
Zhang Ying Supervisors
Liang Yun Bo Core technical personnel
Zhang Jia Hong senior management
Li Guo Directors, senior managers
Ding Zhong Hui Directors, senior managers, core technical personn
Gu Xiao Feng Directors, senior managers
Wu Tong Director
Wu Shi Ming Director
Pei Yan Bin senior management
Wang Xiao Qing Supervisors
Zhang Chao Hui Director

Beijing Succeeder Technology Headlines

No Headlines